Navigation Links
CoolTouch Inc. Settles Diomed Lawsuit, Files Re-examination Request for Cynosure '873 Patent
Date:4/13/2009

ROSEVILLE, Calif., April 13 /PRNewswire/ -- On April 7, 2009, the Boston District Court dismissed the "Diomed" lawsuit between Endolaser Associates, LLC and CoolTouch Inc. after CoolTouch signed a settlement agreement with Dr. Luis Navarro. This patent infringement suit was originally filed in 2004 and relates to the use of lasers for endovenous ablation. CoolTouch will license the '777 Navarro patent and pay royalties on CTEV laser sales and accessories that potentially allow vein wall contact with the emitting part of the fiber.

CoolTouch CEO David R. Hennings states, "We have reached an agreement that recognizes the inventor's pioneering work in the field of endovenous laser ablation and makes business sense for CoolTouch."

In another patent matter, CoolTouch, working with the Boston law firm of McCarter & English LLP, has filed a re-examination request with the U.S. Patent Office of the '873 Paolini laser lipolysis patent assigned to Cynosure, which is the subject of litigation between the parties. CoolTouch requests the re-examination based on prior art by Dr. David Apfelberg and by Mr. David Hennings. CoolTouch has filed for a stay in the litigation until the patent office rules on the validity of this patent. Over 70% of re-examinations by the Patent Office result in claim rejections.

Until the stay is accepted, CoolTouch is confident that the court will also rule in its favor on the issue of non-infringement. On Dec. 22, 2008, the court's Markman ruling rejected Cynosure's attempts to define "adjacent" to mean "in the vicinity of" the tip of the needle. The court said that "adjacent" means "next to" the tip of the needle. The CoolTouch CoolLipo(TM) device uses a fiber that extends 5mm beyond the tip of the cannula and is clearly not "next to" the tip of the cannula.

Recently, the patent office has published two new CoolTouch patent applications that relate to laser-
'/>"/>

SOURCE CoolTouch Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
2. Cynosure Files Patent Infringement Lawsuit Against CoolTouch Inc.
3. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
4. CoolTouch Introduces CoolBlue Duet(TM) Laser Lipolysis Suction Handpiece
5. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
6. CoolTouch Launches CoolLipo Trio Offering Physicians Three Functions in One
7. Cynosure Obtains Favorable Markman Rulings in Patent Infringement Case Against CoolTouch
8. Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB
9. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
10. Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter
11. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... (PRWEB) March 30, 2015 “ iCareTech ” ... Report, which takes a look at the latest and coolest ... NewsWatch special reporter and technology expert, conducted the review and ... band that’s dedicated to the medical and health fields. , ... of conversation over the past couple of years. Well, at ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an article ... new treatment options for dealing with stubborn, unwanted fat. Two ... product. The other three technologies use devices to deliver ultrasound ... cold ( CoolSculpting ) to kill fat cells. (see: goo.gl/NmaB4q) ... to permanently remove unwanted fat," says Dr. Simon Ourian, Medical ...
(Date:3/30/2015)... March 30, 2015 Healthy, radiant skin ... Pharmacy. The staff of pharmacists is specially trained and ... like acne, eczema and other conditions. , Most people ... patient’s dermatologist and/or PCP to tackle most skin conditions ... Pharmacy has employed specialty-trained pharmacists who have experience in ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical ... it is expanding its services into Asia in 2015. ... the world comes at a time when Asia’s strengthening ... better healthcare. A rapidly growing aging population and changing ... in medicine in Asia. “We are excited to be ...
(Date:3/30/2015)... York, NY (PRWEB) March 30, 2015 ... and other neurological diseases plays an important role in ... led by scientists from the Icahn School of Medicine ... , Neurological diseases have long been associated with inflammation, ... that occurs when immune cells home in to attack ...
Breaking Medicine News(10 mins):Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3
... Isabelle Taylor, of St Annes, Lancs, a mobile phone two ... would end up constantly // sending text messages to her ... ‘repetitive strain injury’ and becoming the youngest person in Britain ... explains that she's constantly on the phone messaging. Stating that ...
... the people who are undergoing fertility treatment do not ... apprehensive // about the repercussions .In a survey carried out ... approximately 300 patients, it was observed that the patients ... of their bosses. The survey, done for ...
... of the University of Portsmouth and colleagues a large number ... food intakes because their parents believed that they are ... 54 per cent of a sample group of one-year-olds were ... such food items initiated an allergic reaction in them ...
... properties very close to insulin, bringing hope to the thousands of ... by DIA-B, a biotech company whose chairman is the former federal ... apply for a patent, so your guess is as good as ... Dr Wooldridge, 'The medical and commercial potential this represents would be ...
... by McGill University in Montreal it was found that vitamin ... // . The sun shine vitamin as it is called ... It was also found that pregnant women consuming too little ... Canada, US and Australia met in Toronto and discussed the ...
... that patients who come for emergency treatment at Victoria Hospital ... The emergency ward at the hospital is said to be ... of beds. This has been further worsened with one of ... the last four months. ,He hospital sources have ...
Cached Medicine News:Health News:Role of Vitamin D in Preventing Cancer 2Health News:Victoria Hospital In Bangalore is Lacking Beds In Emergency wards 2
(Date:3/30/2015)... 2015  EP Global Communications, Inc. (OTC-PINK: EPGL) In ... opened negotiations with CooperVision, Inc. at $1.1 billion ... ophthalmic technologies. As previously disclosed publicly, CooperVision, Inc. ... contact lens technologies, which has led to several ... industry experts that just one of these newly ...
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research ... announced the addition of the "Computer Aided ... report to their offering. Annual estimates ... through 2020. Also, a six-year historic analysis is ... are derived from primary and secondary research. Company ...
Breaking Medicine Technology:CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 2CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 3Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 2Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 3Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 4
... Digestive Disease Week (DDW), SAN DIEGO, May ... Digestive Disease Week reaffirm the long-term, sustainable,efficacy and ... in,treating patients with moderate to severe Crohn,s disease. ... responders and the remission,rate remained stable in many ...
... US Employer Claims Suggests a Benefit,of Anti-Tumor Necrosis Factor Therapies on ... ... 20 Data from a new analysis of the,Active Ulcerative Colitis ... than 60 percent of patients with moderately to severely active,ulcerative colitis ...
Cached Medicine Technology:Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8
... Plus Chemistry Analyzer is an in vitro ... of clinical chemistry parameters using Reflotron Test Tabs. ... and ensures rapid and reliable results while being ... clear LC display and the profile can be ...
... ASR contains primers and a FAM-labeled probe targeting ... the Parvo B19 ASR contains primers and a ... This ASR requires an instrument that can detect ... System., The Cepheid Analyte Specific Reagent* (ASR) program ...
... Enterovirus ASR contains primers, a FAM-labeled probe and ... detect a 115 bp region of the 5' ... detect FAM, Alexa 532 and Texas Red reporter ... Analyte Specific Reagent* (ASR) program is comprised of ...
... The B. pertussis ASR contains primers and ... a 103 bp region of the IS481 gene. ... a Texas Red-labeled probe and DNA for an ... that can detect FAM and Texas Red reporter ...
Medicine Products: